CONCERT PHARMACEUTICALS, INC. CNCE Cash Flow

Concert pharmaceuticals, inc. (CNCE)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13
Operating activities
Operating activities
Net Income (Loss) Attributable to Parent
-20,477	-20,487	-17,185	-18,668	-21,826	-20,849	-17,387	-13,325	-4,463	-6,066	128,065	-13,027	-13,333	-12,043	-11,356	-13,441	-13,880	684	-8,554	41,046	-9,002	-8,927	-7,832	-7,990	-6,950	-5,915	-7,127	8,765	-1,779
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
408	408	407	405	444	325	366	256	253	251	256	245	248	245	225	220	210	208	209	185	183	70	332	324	326	340	334	334	338
Stock-based compensation expense
2,477	2,615	2,420	2,362	2,929	2,666	2,731	2,804	3,299	2,787	2,497	1,573	1,643	1,236	1,262	1,287	1,282	826	844	665	646	602	586	295	210	210	232	335	226
Accretion of premiums and discounts on investments
80	114	293	312	294	235	111	70	53	16	-6	-33	-67	-103	-136	-131	-134	-162	-162	-210	-181	-224	-257	-268	-84	-79	-88	-68	-67
Unrealized loss on marketable equity securities
-2,389	-60	335	-126	-2,299	-1,567	-732	669	-1,296	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unrealized loss on marketable equity securities
-2,389	-60	335	-126	-2,299	-1,567	-732	669	-1,296	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on disposal of asset
0	0	0	0	-4	0	-52	0	0	-	-	-	-	0	0	0	-2	0	0	-4	0	-	-	-	-	-	-	-	-
Amortization of discount on loan payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	25	24	25	26	24	24	24	24	24	25	24
Amortization of deferred financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	9	10	9	10	10	9	9	10	9	10	9
Re-measurement of warrant to purchase redeemable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	117	-26	-393	212	211
Amortization of deferred lease incentive
-	-	-	-	-	114	196	197	196	82	81	81	80	80	79	78	78	78	77	77	76	43	67	129	128	-	-	-	-
Non-cash license consideration (Note 12)
-	-	-	-	-	-1	0	0	10,452	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash lease expense
68	65	59	53	49	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of deferred lease incentive
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	128
Changes in operating assets and liabilities:
Accounts receivable
-71	61	-27	27	-4	36	-25	-124	-6	126	-265	260	-14	14	-120	-19	82	-65	42	-30	-898	-224	1,149	28	-102	6	-21	-1,828	2,000
Interest receivable
168	-31	-145	54	-174	43	2	-69	-48	-7	417	42	12	-159	112	-168	198	-50	-50	83	-64	-29	-45	19	225	-22	18	1	-7
Prepaid expenses and other current assets
-539	737	726	746	-381	949	-496	-311	811	-136	-396	-15	980	-80	114	-986	638	659	-305	-908	1,045	-631	-348	-10	1,126	-188	-285	217	224
Contract asset
0	0	0	0	-16,000	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other assets
-14	80	-4	-3	23	-8	-9	-7	-10	-7	-8	-9	-9	48	-3	-70	14	2	-9	-8	-8	-9	34	-9	-98	-1,172	1,159	-9	-47
Accounts payable
563	-424	715	-987	479	-22	274	-53	236	177	-519	-528	983	-910	-947	1,631	270	-1,018	593	-109	444	-893	461	79	321	28	344	-655	441
Accrued expenses and other liabilities
-3,932	3,811	-744	1,305	-1,388	1,365	1,105	1,065	-2,270	943	-499	1,659	-1,667	-179	621	-40	-1,359	984	686	705	-2,598	782	952	1,087	42	-646	-226	419	438
Income taxes receivable
0	0	0	0	36	-1	77	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income taxes payable
0	-2	0	0	-390	-28	142	280	-50	-2,131	2,177	0	0	0	0	0	-75	-11	-423	509	0	-	-	-	-	-	-	-	-
Deferred rent
-	-	-	-	-	713	677	678	678	-35	-23	-22	-22	-22	-10	-10	-9	-10	-20	-18	-20	-11	1	-57	-59	-58	-39	-43	-41
Deferred revenue
-	-	-	-	-	0	0	0	-16	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating lease liability
294	-	-154	-147	-144	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	-17	-	-21	-47	-35	-171	-1,682	-3,045	-753	-1,073	-800	-997	-940	-916	-307	17,829	275
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-10,388	-13,147	-	-10,272	-9,104	-14,470	1,031	-7,906	40,972	-11,036	-7,990	-6,560	-7,115	-8,095	-	-	-	-
Net cash used in operating activities
-17,834	-15,076	-15,660	-16,687	-1,338	-15,614	-11,210	-8,720	-12,485	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	28,790	-2,089
Investing activities
Investing activities
Purchases of property and equipment
112	165	48	157	315	464	884	1,196	325	294	424	79	150	475	64	139	92	141	307	270	150	560	56	88	100	220	36	31	76
Purchases of investments
93,417	4,511	44,118	35,877	13,331	53,315	36,691	1,488	7,941	25,221	116,067	35,295	29,624	5,559	50,879	4,008	71,898	19,722	36,216	101,511	5,576	12,000	2,299	23,457	51,432	1,276	24,027	2,100	2,526
Maturities of investments
33,900	39,399	49,130	36,855	55,721	47,063	30,000	35,030	28,114	24,390	16,874	15,250	29,333	27,975	37,313	29,018	31,595	91,112	43,950	21,400	22,000	12,395	15,975	11,170	6,000	2,115	4,817	8,973	10,750
Net cash provided by (used in) investing activities
-	-	-	-	-	-	-	-	-	-	-	-20,124	-441	-	-13,630	24,871	-40,395	71,249	7,427	-80,381	16,274	-165	13,620	-12,375	-45,532	-	-	-	-
Net cash (used in) provided by investing activities
-59,629	34,723	4,964	821	42,075	-6,716	-7,575	32,346	19,848	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6,842	8,148
Repayments of Long-term Debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	775	2,179	2,132	2,089	2,045	1,998	1,954	1,919	-	-	-	-
Financing activities
Proceeds from exercises of stock options
435	70	36	165	805	103	23	242	669	4,180	940	317	1,139	308	54	63	176	260	764	510	310	-	541	186	105	-	-	-	-
Financing activities
Repayment of leasehold improvement loan
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	83	83	83	83
Proceeds from exercise of warrants
0	0	0	0	1,000	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of leasehold improvement loan
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	83	83	83	-	-	-	-
Proceeds from common stock and pre-funded warrants sold, net of underwriters' discount and costs
70,064	-	-	-	-50	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	46,995	-85,570	0	0	86,579	-	-	-	-
Payment of public offering costs
-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	0	0	276	34	0	0	394	1,042	-	-	-	-
Net cash provided by financing activities
70,499	12	366	-682	1,755	103	23	-964	669	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,284	-83
Net increase in cash and cash equivalents and restricted cash
-6,964	-	-	-	42,492	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash (used in) provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	29,997	1,139	-	54	63	176	-480	-1,378	-1,840	45,182	-1,885	-1,540	-2,245	83,640	-	-	-	-
Net increase in cash and cash equivalents and restricted cash
-	-	-	-	-	-	-18,762	22,662	8,032	-	4,528	-515	-12,449	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net (decrease) increase in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-23,848	15,830	-54,689	71,800	-1,857	-41,249	50,420	-10,040	5,520	-21,735	30,013	-8,974	-29,202	34,348	5,976
Supplemental cash flow information:
Cash paid for income taxes
0	6	9	19	425	73	0	0	50	1,900	0	0	0	-10	0	0	85	0	225	0	0	-	-	-	-	-	-	-	-
Cash paid for interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5	49	95	138	183	229	272	308	351	395	430	425
Purchases of property and equipment unpaid at period end
0	4	-24	8	16	89	-221	-386	706	61	-2	-27	33	-215	212	-41	64	-61	4	7	92	-	-	-	-	-	-	-	-
Tenant improvements paid by landlord (Note 11)
-	-	-	-	-	0	794	2,788	1,414	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Public offering costs unpaid at period end
0	93	0	-106	156	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid included in measurement of lease liabilities
244	-	694	694	694	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pre-funded stock warrants issued
16,736	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Public offering costs incurred but unpaid at period end
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	276	-	-	-	394	-	-	-	-